1. In-Process Quality Control (IPQC) Tests for Capsules
In-process quality control tests are performed during different stages of manufacturing to monitor the product and ensure consistency. These tests help in identifying and correcting deviations before the final product stage.
1.1 Weight Variation Test
Purpose: To ensure consistent dosage of the active pharmaceutical ingredient (API) in each capsule.
Method: A certain number of capsules (typically 10) are weighed individually, and the average weight is calculated. The individual weights are then compared to this average.
Acceptance Criteria: The weight variation should be within specified limits, usually ±7.5% for capsules with a fill weight of 300 mg or less and ±5% for capsules with a fill weight above 300 mg.
1.2 Moisture Content
Purpose: To maintain the integrity of the gelatin capsule shell, as gelatin is sensitive to moisture levels.
Method: Measured using a moisture analyzer or Karl Fischer titration method.
Acceptance Criteria: Moisture content should typically be between 12-16% to prevent brittleness or softening of the capsules.
1.3 Flow Properties of Powder Blend
Purpose: To ensure that the powder blend flows uniformly during filling.
Methods:
Angle of Repose: Determines the flowability of the powder by measuring the angle formed by a heap of the powder.
Bulk and Tapped Density: Determines the compressibility and flow characteristics.
Carr’s Index and Hausner Ratio: Provides a quantitative measure of flow properties.
Acceptance Criteria: Good flow properties are indicated by a Carr’s Index < 20% and a Hausner Ratio < 1.25.
1.4 Capsule Locking and Sealing Integrity
Purpose: To ensure that the capsules are properly closed, avoiding leakage or loss of fill material.
Method: Physical inspection and testing of the locking mechanism or use of banding techniques if required.
Acceptance Criteria: Capsules should remain intact under specified conditions.
1.5 Powder Fineness and Uniformity
Purpose: To confirm that the particle size and uniformity of the powder blend meet the requirements for consistent drug release.
Method: Sieving, microscopic examination, or laser diffraction.
Acceptance Criteria: Based on the formulation requirements; typically, 90% of the powder should pass through a specified mesh size.
1.6 Fill Weight Variation
Purpose: To ensure that each capsule contains the precise fill weight.
Method: Capsules are sampled periodically during filling, and individual weights are compared to the target weight.
Acceptance Criteria: Fill weight should be within the specified range (typically ±5% of the target weight).
1.7 Capsule Hardness and Shell Thickness
Purpose: To ensure that the shell is durable enough to protect the contents while allowing for proper disintegration.
Method: Thickness gauges or hardness testers are used to measure shell thickness and hardness.
Acceptance Criteria: Capsule shell thickness and hardness should fall within manufacturer specifications.
2. Final Product Quality Control Tests for Capsules
Final product quality control tests are conducted after the manufacturing process is complete. These tests verify that the finished product meets all specifications before it is released for distribution.
2.1 Uniformity of Content
Purpose: To confirm that each capsule contains the specified amount of active ingredient.
Method: Typically, 10 capsules are selected, and each capsule is assayed individually to measure the amount of active ingredient.
Acceptance Criteria: Content uniformity should generally fall within 85% to 115% of the labeled claim, with a relative standard deviation (RSD) of less than 6%.
2.2 Disintegration Test
Purpose: To ensure that the capsule shell breaks down within a specified time in the gastrointestinal tract.
Method: Capsules are placed in a disintegration tester with simulated gastric fluid (for capsules intended for stomach release) or simulated intestinal fluid (for enteric-coated capsules).
Acceptance Criteria: Capsules should disintegrate within 30 minutes for uncoated capsules and 60 minutes for coated capsules unless otherwise specified.
2.3 Dissolution Test
Purpose: To measure the rate and extent of drug release from the capsule, which impacts bioavailability.
Method: Capsules are placed in a dissolution apparatus, and the amount of drug released is measured over time in a medium that simulates the GI environment.
Acceptance Criteria: Typically, 75% of the drug should dissolve within 45 minutes, though criteria may vary depending on the formulation.
2.4 Stability Testing
Purpose: To evaluate the stability of the capsules over time, including their potency, physical integrity, and dissolution profile.
Method: Stability testing includes accelerated (e.g., 40°C/75% RH for 6 months) and long-term stability studies (e.g., 25°C/60% RH for 12–24 months).
Acceptance Criteria: Capsules should maintain their physical, chemical, and microbial integrity throughout the specified shelf life.
2.5 Friability Test
Purpose: To ensure the capsule shells are resistant to chipping or cracking.
Method: Capsules are tumbled in a friability tester, and weight loss is measured.
Acceptance Criteria: Capsules should not lose more than 0.5–1.0% of their weight.
2.6 Microbial Limits Test
Purpose: To ensure the capsules are free from microbial contamination.
Method: Capsules are tested for total viable count, as well as for specific pathogens (e.g., E. coli, Salmonella, S. aureus).
Acceptance Criteria: Capsules should meet the microbial limits specified in pharmacopeial standards (e.g., USP, Ph. Eur.).
2.7 Visual Inspection and Physical Appearance
Purpose: To ensure capsules are uniform in color, shape, and size, and free from physical defects.
Method: Visual inspection under adequate lighting conditions.
Acceptance Criteria: Capsules should be free from cracks, spots, or other defects and should have a uniform appearance.
2.8 Weight Variation (Final Product Test)
Purpose: To confirm that the capsule’s weight meets specifications.
Method: Weigh 20 capsules individually, calculate the average weight, and compare individual weights to this average.
Acceptance Criteria: The average fill weight should not deviate from the target weight by more than ±5%.
2.9 Identification Test
Purpose: To confirm the identity of the active ingredient(s) in the capsule.
Method: Analytical techniques such as high-performance liquid chromatography (HPLC), gas chromatography (GC), or infrared (IR) spectroscopy.
Acceptance Criteria: Results should match the reference standard of the active ingredient.
2.10 Assay of Active Ingredient(s)
Purpose: To measure the exact amount of active ingredient(s) in the finished product.
Method: Chemical analysis using methods such as HPLC or spectrophotometry.
Acceptance Criteria: The active ingredient content should be within the specified range (typically 90-110% of the labeled claim).
Conclusion
These in-process and final product quality control tests are essential for producing high-quality, consistent, and effective capsule products. Ensuring compliance with regulatory guidelines and good manufacturing practices (GMP) is crucial for the safety and efficacy of pharmaceutical capsules.
